NCT04406454View on ClinicalTrials.gov

The Application of Non-invasive and Cellular Level Resolution Fullfield Optical Coherence Tomography: Establishment and Analysis of Subcutaneous Cellular Level Image Database of Anatomical Locations in Healthy Volunteers and Evaluation of Usability

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

July 6, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

February 8, 2022

Conditions
Healthy SkinNevus
Interventions
DEVICE

ApolloVue® S100 Image System

The device is an in vivo non-invasive optical coherence tomography and will be used to obtain at least 3 quality OCT images of B-scan (cross-section) and E-scan (en face) with 4 depths for each skin site respectively for each skin site. There is a total of 6 skin sites.

Trial Locations (1)

11217

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
collaborator

Apollo Medical Optics, Ltd

INDUSTRY

lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

NCT04406454 - The Application of Non-invasive and Cellular Level Resolution Fullfield Optical Coherence Tomography: Establishment and Analysis of Subcutaneous Cellular Level Image Database of Anatomical Locations in Healthy Volunteers and Evaluation of Usability | Biotech Hunter | Biotech Hunter